Helius Medical Launches $500M Solana Treasury: Shares Surge 250%

Pantera-Backed Helius Medical Launches $500M Solana Treasury Company

Helius Medical Technologies (NASDAQ: HSDT) has shocked many by shifting from being known as a neurotech company to the blockchain world. The company announced raising more than $500 million to create a Solana-focused treasury company. Backed by leading investors such as Pantera and Summer Capital, this move has caused Helius shares to rise by almost 250% in a single day.

Funding Announcement

On September 15, 2025, Helius confirmed the completion of an oversubscribed private equity round worth $500 million. Alongside this, the company also issued warrants worth $750 million, potentially unlocking more than $1.25 billion in future capital.

The funding round was co-led by Pantera, the first U.S. institutional blockchain-focused asset manager, and Summer Capital, an early licensed Asian crypto fund manager. Other participants included Animoca Brands, FalconX, HashKey Capital, Avenir, SinoHope, Arrington Capital, Big Brain Holdings, Borderless, Aspen Digital, Laser Digital, and Republic Digital.

Source: Official Website

Leadership and Strategy

The $SOL treasury strategy will be guided by a team with deep experience in both global markets and digital assets.

• Joseph Chee, Founder of Summer Capital and former UBS Asia investment banking head, joins as Executive Chairman.

• Cosmo Jiang, General Partner at Pantera Capital, joins as Board Observer.

• Dan Morehead, Pantera’s Founder and Managing Partner, will act as Strategic Advisor.

This leadership group is focused on maximizing $SOL holdings per share to establish a vehicle akin to Michael Saylor's Bitcoin strategy with MicroStrategy.

Why Solana?

Helius is planning to buy $SOL as its main treasury reserve asset. SOL has become known as one of the fastest and most efficient blockchains:

• 3,500+ transactions per second

• 23 billion transactions handled this year

• 3.7 million daily active wallets

Unlike Bitcoin, which does not generate yield, Solana offers a ~7% staking return, making it financially productive. Helius also plans to dive into DeFi opportunities, staking, and lending to bring in more revenue.

Source: BNBswap official X

Market Reaction

Following the announcement, Helius stock (HSDT) skyrocketed by nearly 200-250% showing the great enthusiasm from investors. The company expects the offering to be completed by September 18, 2025, after which its Solana treasury operations will commence. Helius pointed out that it will be transparent in reporting its SOL holdings, governance policies, and ecosystem participation.

Broader Implications

By promoting itself as a Solana treasury leader, the company is emphasizing the fact that the adoption of blockchain is no longer limited to crypto-native companies but is spreading across traditional industries.

Investors and analysts indicate that this strategy has the potential to speed up Solana's adoption across the globe by opening new channels in the capital markets and drawing in institutional participation.

Source: Coindesk

Impact on the Crypto Market 

This radical shift of Helius Medical in favor of $SOL reinforces the role of this company in the crypto market and indicates the increased confidence of institutions. This move has the potential to increase liquidity, staking activity, and participation in DeFi on Solana because it has $500M of funding and could scale to $1.25B. It also echoes MicroStrategy's strategy for Bitcoin, a reinforcement of the concept of digital assets as corporate treasury reserves.

Conclusion

The $500 million funding round and transition are one of the most cross-industry changes of 2025. The pantera captial launch Solana treasury targeting $1.2B Fund is a positive sign of an increasing institutional interest in the future of the blockchain.